.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Teva
Fuji
Dow
Medtronic
Argus Health
AstraZeneca
Queensland Health
Cipla
Cerilliant

Generated: September 21, 2017

DrugPatentWatch Database Preview

Switzerland Supplementary Protection Certificates

« Back to Dashboard

These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.

Country Document Number Supplementary Protection Certificate SPC Country SPC Description SPC Expiration
European Patent Office1084705C01084705/01SwitzerlandPRODUCT NAME: SITAGLIPTIN; REGISTRATION NO/DATE: SWISSMEDIC 57863 18.04.2007► Subscribe
European Patent Office0706513C00706513/01SwitzerlandFORMER OWNER: NYCOMED GERMANY HOLDING GMBH, DE► Subscribe
European Patent Office0785926C00785926/01SwitzerlandFORMER OWNER: ABBVIE DEUTSCHLAND GMBH AND CO. KG, DE► Subscribe
European Patent Office0904081C00904081/01SwitzerlandPRODUCT NAME: PALIPERIDON PALMITATESTER; REGISTRATION NO/DATE: SWISSMEDIC 60466 20101215► Subscribe
European Patent Office1564210C01564210/01SwitzerlandPRODUCT NAME: ELVITEGRAVIR; REGISTRATION NO/DATE: SWISSMEDIC 62673 18.10.2013► Subscribe
European Patent Office1003774C01003774/01SwitzerlandPRODUCT NAME: DEGARELIX; REGISTRATION NUMBER/DATE: SWISSMEDIC 59455 12.02.2010► Subscribe
European Patent Office0716600C00716600/01SwitzerlandPRODUCT NAME: NEPAFENAC; REGISTRATION NUMBER/DATE: SWISSMEDIC 58745 24.09.2008► Subscribe
European Patent Office1304992C01304992/01SwitzerlandPRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014► Subscribe
European Patent Office0806968C00806968/01SwitzerlandFORMER REPRESENTANTIVE: BOVARD AG PATENTANWAELTE, CH► Subscribe
European Patent Office1028961C01028961/01SwitzerlandPRODUCT NAME: RETAPAMULIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58641 04.08.2009► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Harvard Business School
Daiichi Sankyo
Covington
Farmers Insurance
Express Scripts
McKesson
Deloitte
QuintilesIMS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot